The usefulness of 99mTc-SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology

European Journal of Endocrinology

Volumn 149, Issue 6, 2003, Pages 493-498

  Boi, F ^a   Lai, M L ^a   Deias, C ^a   Piga, M ^a   Serra, A ^a   Uccheddu, A ^a   Faa, G ^a   Mariotti, S ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MEDICAL ASSESSMENT; METAPLASIA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THYROID CANCER; THYROID NODULE; THYROID PARAFOLLICULAR CELL; THYROID SCINTISCANNING; THYROID TUMOR; CLINICAL TRIAL; MIDDLE AGED; NEEDLE BIOPSY; ONCOCYTOMA; PATHOLOGY; SCINTISCANNING; THYROID DISEASE;

ADENOMA, OXYPHILIC; ADULT; AGED; BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYPHIL CELLS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; THYROID DISEASES; THYROID NODULE;

EID: 0346728605     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1490493     Document Type: Article

References (29)

1. Gonzalez JL, Wang HH & Ducatman BS. Fine-needle aspiration of Hürthle cell lesions. A cytomorphologic approach to diagnosis. American Journal of Clinical Pathology 1993 100 231-235.
2. Grant CS. Operative and postoperative management of the patient with follicular and Hürthle cell carcinoma. Do they differ? Surgical Clinics of North America 1995 75 395-403.
3. Bronner M & Li Volsi V. Oxyphilic (Askanazy/Hürthle cell) tumors of the thyroid: microscopic features predict biological behaviour. Surgical Pathology 1988 1 137-150.
4. Carcangiu ML, Bianchi S, Savino D, Voynick IM & Rosai J. Follicular Hürthle cell tumors of the thyroid gland. Cancer 1991 68 1944-1953.
5. McIvor NP, Freeman JL, Rosen I & Bedard YC. Value of fine-needle aspiration in the diagnosis of Hürthle cell neoplasms. Head and Neck 1993 15 335-341.
6. Li Volsi V. Surgical Pathology of the Thyroid, pp 272-288. Philadelphia: WB Saunders, 1990.
7. Har-El G, Hadar T, Segal K, Levy R & Sidi J. Hürthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy. Cancer 1986 57 1613-1617.
8. Beckner ME, Heffess CS & Oertel JE. Oxyphilic papillary thyroid carcinomas. American Journal of Clinical Pathology 1995 103 280-287.
9. Cheung CC, Ezzat S, Ramyar L, Freeman JL & Asa SL. Molecular basis of Hürthle cell papillary thyroid carcinoma. Journal of Clinical Endocrinolgy and Metabolism 2000 85 878-882.
10. Belfiore A & La Rosa GL. Fine-needle aspiration biopsy of the thyroid. Endocrinology and Metabolism Clinics of North America 2001 30 361-400.
11. Renshaw AA. Accuracy of thyroid fine-needle aspiration using receiver operator characteristic curves. American Journal of Clinical Pathology 2001 116 477-482.
12. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. Journal of Clinical Endocrinolgy and Metabolism 2002 87 1941-1946.
13. Gharib H. Changing concepts in the diagnosis and management of thyroid nodules. Endocrinology and Metabolism Clinics of North America 1997 26 777-800.
14. Baillet GY, Mena IG, Kuperus JH, Robertson JM & French WJ. Simultaneous technetium-99m MIBI angiography and myocardial perfusion imaging. Journal of Nuclear Medicine 1989 30 38-44.
15. Iskandrian AS, Heo J, Kong B, Lyons E & Marsch S. Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease, and comparison with coronary arteriography and exercise thallium-201 SPECT imaging. American Journal of Cardiology 1989 64 270-275.
16. Kiat H, Maddahi J, Roy LT, Van Train K, Friedman J, Resser K et al. Comparison of technetium 99m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods. American Heart Journal 1989 117 1-11.
17. Taillefer R, Lambert R, Dupras G, Gregoire J, Leveille J, Essiambre R et al. Clinical comparison between thallium-201 and Tc-99m-methoxy isobutyl isonitrile (hexamibi) myocardial perfusion imaging for detection of coronary artery disease. European Journal of Nuclear Medicine 1989 15 280-286.
18. Aktolun C, Bayhan H & Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors. Preliminary results and comparison with Tl-201. Clinical Nuclear Medicine 1992 17 171-176.
19. Geatti O, Shapiro B, Orsolon PG, Proto G, Guerra UP, Antonucci F et al. Localization of parathyroid enlargement: experience with technetium-99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasonography and computed tomography. European Journal of Nuclear Medicine 1994 21 17-22.
20. Hassan IM, Sahweil A, Constantinides C, Mahmoud A, Nair M, Omar YT et al. Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs. Clinical Nuclear Medicine 1989 14 333-340.
21. Taillefer R, Boucher Y, Potvin C & Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). Journal of Nuclear Medicine 1992 33 1801-1807.
22. Balon HR, Fink-Bennet TD & Stoffer SS. Technetium-99m-sestamibi uptake by recurrent Hürthle cell carcinoma of the thyroid. Journal of Nuclear Medicine 1992 33 1393-1395.
23. Foldes I, Levay A & Stotz G. Comparative scanning of thyroid nodules with technetium-99m pertechnetate and technetium-99m methoxyisobutylisonitrile. European Journal of Nuclear Medicine 1993 20 330-333.
24. Nakahara H, Noguchi S, Murakami N, Hoshi H, Jinnouchi S, Nagamachi S et al. Technetium-99m-sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumors. Journal of Nuclear Medicine 1996 37 901-904.
25. Scott AM, Kostakoglu L, O'Brien JP, Straus DJ, Abdel-Dayem HM & Larson SM. Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma. Journal of Nuclear Medicine 1992 33 1396-1398.
26. Vattimo A, Bertelli P & Burroni L. Effective visualization of suppressed thyroid tissue by means of baseline 99mTc-methoxy isobutyl isonitrile in comparison with 99mTc-pertechnetate scintigraphy after TSH stimulation. Journal of Nuclear Biology Medicine 1992 36 315-318.
27. Vattimo A, Bertelli P, Cintorino M, Burroni L, Volterrani D & Vella A. Identification of Hürthle cell tumor by single-injection, double-phase scintigraphy with technetium-99m-sestamibi. Journal of Nuclear Medicine 1995 36 778-782.
28. Bogazzi F, Bartalena L, Brogioni S, Burelli A, Manetti L, Tanda ML et al. Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow Doppler sonography. European Journal of Endocrinology 1999 140 452-456.
29. Galen RS & Gambino RS. In How to determine the predictive value and efficiency of a test when reading a scientific paper. Beyond normality: The predictive value and efficiency of medical diagnoses, pp 29-40. New York: John Wiley & Sons, 1975.